DSIJ Mindshare

Traders show fresh interest in Medicamen Biotech! Is it the right time to buy?

In its recent quarterly result, the company reported over a 20 per cent jump in sales YoY and stood at Rs 33.09 crore. Medicamen Biotech is up by over 28 per cent in the last three months.  

Rohit Kale 0 922 Article rating: 4.8

The stock soared over a massive 15 per cent during the initial hours of Friday’s trading session despite weakness in the market.

Overnight Digest: Stocks likely to be in focus on August 17

Keep an eye on these stocks for Wednesday's trading session.

Shreya Chaware 0 971 Article rating: 4.4

The domestic markets maintained a positive momentum through the trading session supported by optimistic global cues and a few domestic factors which caused a rally in realty, automobile and banking stocks. Sensex ended 379.43 points or 0.64 per cent up at 59,842.21 while Nifty settled 127.10 points or 0.72 per cent up at 17,825.30 level. 

These top stocks are experiencing a golden crossover; do you hold any?

Do you want to look at long-term trend action? Nothing beats searching for a Golden Crossover. We have highlighted the best Nifty 500 stocks with a golden crossing in this post.

Henil Shah 1 5377 Article rating: 3.8

Do you want to look at long-term trend action? Nothing beats searching for a Golden Crossover. We have highlighted the best Nifty 500 stocks with a golden crossing in this post.

These stocks are experiencing price volume breakout

On July 5, the Nifty 50 attempted to rise but was met with rejections at higher levels, with sellers taking the lead. There are, however, pockets of strength. In this post, we have highlighted companies that are experiencing price volume breakout.

Henil Shah 0 1801 Article rating: 3.1

On July 5, the Nifty 50 attempted to rise but was met with rejections at higher levels, with sellers taking the lead. There are, however, pockets of strength. In this post, we have highlighted companies that are experiencing price volume breakout.

RSS
135678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR